The ultimate goal of bacterial based cancer therapy is to achieve non-toxic penetration and colonization of the tumour microenvironment. To overcome this efficacy-limiting toxicity of anticancer immunotherapy, we have tested a therapy comprised of systemic delivery of a vascular disrupting agent to induce intratumoral necrotic space, cannabidiol to temporarily inhibit angiogenesis and acute inflammation, and a strain of Salmonella Typhimurium that was engineered for nontoxic colonization and expression of immunomodulators within the tumour microenvironment. This combination treatment strategy was administered to transgenic mice burdened with autochthonous mammary gland tumours and demonstrated a statistically significant 64% slower tumour growth and a 25% increase in mean survival time compared to control animals without treatment. These experiments were accomplished with minimal toxicity as measured by less than 7% weight loss and a return to normal weight gain within three days following intravenous administration of the bacteria. Thus, nontoxic, robust colonization of the microenvironment was achieved to produce a significant antitumor effect.
Keywords: anti-CTLA-4; anti-PD-L1; bacterial cancer therapy; interleukin-15.
Salmonella enterica Typhimurium engineered for nontoxic systemic colonization of autochthonous tumors.
J Drug Target. 2020 Sep 10:1-6. doi: 10.1080/1061186X.2020.1818759. Online ahead of print. J Drug Target. 2020. PMID: 32886538
Low dose chemotherapy combined with attenuated Salmonella decreases tumor burden and is less toxic than high dose chemotherapy in an autochthonous murine model of breast cancer.
Surgery. 2018 Mar;163(3):509-514. doi: 10.1016/j.surg.2017.09.036. Epub 2017 Dec 8. Surgery. 2018. PMID: 29229318
Attenuated Salmonella enterica Typhimurium reduces tumor burden in an autochthonous breast cancer model.
Anticancer Res. 2015 Feb;35(2):843-9. Anticancer Res. 2015. PMID: 25667465
Targeted cancer immunotherapy with genetically engineered oncolytic Salmonella typhimurium.
Cancer Lett. 2020 Jan 28;469:102-110. doi: 10.1016/j.canlet.2019.10.033. Epub 2019 Oct 24. Cancer Lett. 2020. PMID: 31666180 Review.
Tumor-targeting amino acid auxotrophic Salmonella typhimurium.
Amino Acids. 2009 Sep;37(3):509-21. doi: 10.1007/s00726-009-0261-8. Epub 2009 Mar 17. Amino Acids. 2009. PMID: 19291366 Review.